Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research focused on Clear cell renal cell carcinoma and Renal cell carcinoma, with related work in DNA methylation, Prostate cancer, Cancer research. Notable publications include 'Comparison of 68Ga-labelled PSMA-11 and 11C-choline in the detection of prostate cancer metastases by PET/CT', 'Survival Prediction of Clear Cell Renal Cell Carcinoma Based on Gene Expression Similarity to the Proximal Tubule of the Nephron', and 'Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin'.
Drug targeting of the monocarboxylate transporter MCT4 is a novel treatment strategy for metastatic ccRCC
Aktuelle Evidenz zum intraoperativen Ultraschall
Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin
Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma
Results of a Phase 1/2 Study in Metastatic Renal Cell Carcinoma Patients Treated with a Patient-specific Adjuvant Multi-peptide Vaccine after Resection of Metastases
Comparison of 68Ga-labelled PSMA-11 and 11C-choline in the detection of prostate cancer metastases by PET/CT
Methylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenes
MRT/TRUS-fusionierte Biopsiesysteme
Survival Prediction of Clear Cell Renal Cell Carcinoma Based on Gene Expression Similarity to the Proximal Tubule of the Nephron
MCT4 surpasses the prognostic relevance of the ancillary protein CD147 in clear cell renal cell carcinoma
Checkpoint modulation - A new way to direct the immune system against renal cell carcinoma
Direct Comparison of Targeted MRI-Guided Biopsy with Systematic Transrectal Ultrasound-Guided Biopsy in Patients with Previous Negative Prostate Biopsies
IMA901 for Metastatic Renal Cell Carcinoma in the Context of new Approaches to Immunotherapy
Minimally invasive percutaneous nephrolithotomy: an alternative to retrograde intrarenal surgery and shockwave lithotripsy
Second-line systemic therapy for the treatment of metastatic renal cell cancer